Roche
ROG.SW
$274.16
Share price
0.30%
Change (1 day)
-17.36%
Change (1 year)
Categories
Roche (ROG.SW) - Total debt
Total debt on the balance sheet as of December 2022 : $28.73 B
According to Roche's latest financial reports the company's total debt is $28.73 B. A company’s total debt is the sum of all current and non-current debts.
Roche - Total debt on balance sheet (from 2006 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $28.73 B | -19.35% |
| 2021-12-31 | $35.62 B | 103.8% |
| 2020-12-31 | $17.48 B | 8.67% |
| 2019-12-31 | $16.08 B | -15.7% |
| 2018-12-31 | $19.08 B | -2% |
| 2017-12-31 | $19.47 B | -11.27% |
| 2016-12-31 | $21.94 B | -6.75% |
| 2015-12-31 | $23.53 B | -9.53% |
| 2014-12-31 | $26.01 B | 23.79% |
| 2013-12-31 | $21.01 B | -22.01% |
| 2012-12-31 | $26.94 B | -5.87% |
| 2011-12-31 | $28.62 B | -11.01% |
| 2010-12-31 | $32.16 B | -21.57% |
| 2009-12-31 | $41.01 B | 946.05% |
| 2008-12-31 | $3.92 B | -35.36% |
| 2007-12-31 | $6.06 B | -10.48% |
| 2006-12-31 | $6.77 B | -7.81% |
| 2005-12-31 | $7.34 B | -6.45% |
| 2004-12-31 | $7.85 B | -36.45% |
| 2003-12-31 | $12.36 B | -51.41% |
| 2002-12-31 | $25.44 B | -5.82% |
| 2001-12-31 | $27.01 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $52.90 B | 84.13% | 🇺🇸 USA |
 Novartis NVS | $28.34 B | -1.37% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.92 B | 21.55% | 🇺🇸 USA |
 Abbott Laboratories ABT | $16.90 B | -41.18% | 🇺🇸 USA |
 Amgen AMGN | $61.54 B | 114.19% | 🇺🇸 USA |
 Sanofi SNY | $22.85 B | -20.47% | 🇫🇷 France |
 Becton Dickinson BDX | $16.78 B | -41.59% | 🇺🇸 USA |
 Merck MRK | $30.74 B | 7.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $27.08 B | -5.72% | 🇬🇧 UK |